IMS Health Economics and Outcomes Research has experience in supporting customers in achieving market access throughout the product life cycle
Health Economics and Outcomes Research is increasingly used to support the decision making process and disease management:
-
Economic evaluations are playing an important role earlier in the product life cycle and going hand in hand with pricing studies
-
Geographical needs are expanding with a focus also on emerging markets
-
New types of outcomes need addressing (e.g. willingness of pay, adjusted QALYs)
-
Method-specific guidelines are emerging (e.g. for models or retrospective data)
-
Increasing need for sound budget impact studies
In addition, more and more authorities wish to understand of the impact of products or medical technologies in "real life" rather than clinical trials. Post-launch observational patient data can play an important role in addressing:
-
Compliance with medical guidelines
-
Patient persistence and compliance
-
"Real life" target population (indications) and positioning
-
Co-prescriptions
-
Treatment changes, resource use
-
Treatment duration
-
Burden of disease
(*click on image for larger version)